Research report: Omega-3 fatty acids in aromatase inhibitor-associated dyslipidemia: mechanisms, clinical evidence, and future perspectives
A new review finds a strong biological rationale for omega-3 fatty acids in aromatase inhibitor-associated dyslipidemia but says clinical evidence ...










